Aro Biotherapeutics
Rebecca Meyer has a background in Biological Sciences and Cell/Cellular and Molecular Biology. Rebecca has worked as a Medical Technologist at Quest Diagnostics and Mayo Medical Laboratories. Rebecca then transitioned into roles at T2 Biosystems and The Children's Hospital of Philadelphia as a QC Associate and Research Assistant II, respectively. Currently, Rebecca holds the position of Investigator at Aro Biotherapeutics, where Rebecca has progressed from Associate Scientist to Scientist III and IV.
Aro Biotherapeutics
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.